Market/Sales
PersonMentions
0
Relationships
0
Events
0
Documents
0
Relationship Network
Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons.
Drag nodes to reposition. Node size indicates connection count.
Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak).
Use legend and help buttons in the graph for more guidance.
No relationships found for this entity.
No events found for this entity.
No documents found for this entity.
Total Received
$0.00
0 transactions
Total Paid
$1,872,100,000.00
10 transactions
Net Flow
-$1,872,100,000.00
10 total transactions
| Date | Type | From | To | Amount | Description | Actions |
|---|---|---|---|---|---|---|
| 2018-12-31 | Paid | Market/Sales | Level Brands (LEVB) | $1,500,000.00 | Most Recent Quarterly Revenue (Ended 12/18) | View |
| 2018-10-31 | Paid | Market/Sales | 1933 Industries | $4,600,000.00 | Most Recent Quarterly Revenue (Ended 10/18) | View |
| 2018-09-30 | Paid | Market/Sales | Charlotte's Web (... | $17,700,000.00 | Most Recent Quarterly Revenue | View |
| 2018-09-30 | Paid | Market/Sales | Green Thumb Indus... | $17,200,000.00 | Most Recent Quarterly Revenue | View |
| 2018-09-30 | Paid | Market/Sales | CV Sciences | $13,600,000.00 | Most Recent Quarterly Revenue | View |
| 2018-09-30 | Paid | Market/Sales | Tilray (TLRY) | $10,000,000.00 | Most Recent Quarterly Revenue | View |
| 2018-09-30 | Paid | Market/Sales | Elixinol | $7,400,000.00 | Most Recent Quarterly Revenue | View |
| 2018-09-30 | Paid | Market/Sales | Turning Point Bra... | $78,700,000.00 | Most Recent Quarterly Revenue | View |
| 2018-09-30 | Paid | Market/Sales | Curaleaf (CURA) | $21,400,000.00 | Most Recent Quarterly Revenue | View |
| 2001-01-01 | Paid | Market/Sales | TomTom NV | $1,700,000,000.00 | Revenues increased from $2.5 million in 2001 to... | View |
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity